Humana (NYSE:HUM) PT Lowered to $381.00

Humana (NYSE:HUM) had its target price cut by Jefferies Financial Group from $411.00 to $381.00 in a report released on Monday, Benzinga reports. They currently have a buy rating on the insurance provider’s stock.

A number of other analysts have also recently issued reports on HUM. Argus cut shares of Humana from a buy rating to a hold rating in a research note on Wednesday, March 13th. UBS Group reiterated a neutral rating and issued a $370.00 target price (down from $530.00) on shares of Humana in a research note on Friday, January 26th. Deutsche Bank Aktiengesellschaft cut shares of Humana from a buy rating to a hold rating and reduced their target price for the company from $595.00 to $360.00 in a research note on Thursday, January 25th. Mizuho reduced their target price on shares of Humana from $550.00 to $400.00 and set a buy rating for the company in a research note on Friday, January 26th. Finally, StockNews.com cut shares of Humana from a strong-buy rating to a hold rating in a research note on Friday, January 26th. Eleven analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of Hold and an average target price of $454.63.

Humana Stock Performance

Shares of HUM opened at $325.30 on Monday. The company’s 50 day moving average price is $330.09 and its 200 day moving average price is $399.70. Humana has a 52 week low of $299.23 and a 52 week high of $541.21. The company has a market capitalization of $39.25 billion, a PE ratio of 16.41, a PEG ratio of 1.92 and a beta of 0.45. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.59 and a current ratio of 1.59.

Humana (NYSE:HUM) last announced its quarterly earnings data on Thursday, January 25th. The insurance provider reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The company had revenue of $26.46 billion for the quarter, compared to analysts’ expectations of $25.47 billion. During the same period in the previous year, the firm posted $1.62 earnings per share. The business’s revenue for the quarter was up 17.9% on a year-over-year basis. Research analysts expect that Humana will post 16.06 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.09%. The ex-dividend date is Friday, June 28th. Humana’s payout ratio is currently 17.86%.

Insider Activity at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the stock in a transaction on Tuesday, February 20th. The shares were purchased at an average price of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now directly owns 2,578 shares of the company’s stock, valued at approximately $946,358.02. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.29% of the company’s stock.

Institutional Investors Weigh In On Humana

Several institutional investors and hedge funds have recently bought and sold shares of HUM. Ronald Blue Trust Inc. increased its holdings in Humana by 26.8% in the 3rd quarter. Ronald Blue Trust Inc. now owns 189 shares of the insurance provider’s stock valued at $84,000 after buying an additional 40 shares during the period. B & T Capital Management DBA Alpha Capital Management grew its holdings in shares of Humana by 7.1% in the 3rd quarter. B & T Capital Management DBA Alpha Capital Management now owns 7,463 shares of the insurance provider’s stock worth $3,631,000 after purchasing an additional 496 shares during the last quarter. Meridian Wealth Management LLC grew its holdings in shares of Humana by 71.3% in the 3rd quarter. Meridian Wealth Management LLC now owns 6,912 shares of the insurance provider’s stock worth $3,363,000 after purchasing an additional 2,876 shares during the last quarter. Exchange Traded Concepts LLC grew its holdings in shares of Humana by 103.0% in the 3rd quarter. Exchange Traded Concepts LLC now owns 2,883 shares of the insurance provider’s stock worth $1,403,000 after purchasing an additional 1,463 shares during the last quarter. Finally, Caprock Group LLC grew its holdings in shares of Humana by 3.6% in the 3rd quarter. Caprock Group LLC now owns 1,421 shares of the insurance provider’s stock worth $693,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.